Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 days ago

TENAX THERAPEUTICS, INC.: Sirenia Capital Management LP discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Sirenia Capital Management LP disclosed a stake of more than 5% in Tenax Therapeutics, Inc. via a Schedule 13G filing with the SEC (accession 0000919574-26-007956). The 13G designation signals a passive investment position rather than an activist campaign. The exact share count and percentage were not specified in the filing headline. The disclosure makes Sirenia a significant holder in the clinical-stage biopharmaceutical company. Investors will watch for further 13G amendments or 13D filings that could indicate a shift toward active engagement.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Tenax Therapeutics, Inc., Sirenia Capital Management LP